Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Alaunos Therapeutics, Inc. | Director | Common Stock | 25.9K | $51.8K | $2.00 | Dec 31, 2024 | Direct |
Mountain Lake Acquisition Corp. | Director | Class B ordinary shares, par value $0.0001 per share | 1.29M | Dec 16, 2024 | Indirect | ||
Mountain Lake Acquisition Corp. | Director | Class A Ordinary Share, par value $0.0001 per share | 25K | Dec 16, 2024 | Indirect | ||
Alaunos Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 12.8K | Jun 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TCRT | Alaunos Therapeutics, Inc. | Dec 31, 2024 | 2 | -$6.02K | 4 | Jan 3, 2025 | Director |
MLAC | Mountain Lake Acquisition Corp. | Dec 12, 2024 | 4 | $0 | 4 | Dec 16, 2024 | Director |
MLAC | Mountain Lake Acquisition Corp. | Dec 12, 2024 | 0 | $0 | 3 | Dec 16, 2024 | Director, 10%+ Owner |
TCRT | Alaunos Therapeutics, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director |
TCRT | Alaunos Therapeutics, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
TCRT | Alaunos Therapeutics, Inc. | Nov 29, 2022 | 1 | $813K | 4 | Dec 1, 2022 | Director |
TCRT | Alaunos Therapeutics, Inc. | Jun 22, 2022 | 2 | $0 | 4 | Jun 24, 2022 | Director |
TCRT | ZIOPHARM ONCOLOGY INC | Sep 29, 2021 | 1 | $191K | 4 | Oct 4, 2021 | Director |